Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
The Lancet. Respiratory Medicine|December 2, 2024
Idiopathic inflammatory myopathies related lung disease in adultsSameep Sehgal, Aditi Patel, Soumya Chatterjee, et al.
Brain : a Journal of Neurology|April 12, 2024
Apilimod dimesylate in C9orf72 amyotrophic lateral sclerosis: a randomized phase 2a clinical trialSuma Babu, Katharine A Nicholson, Jeffrey D Rothstein, et al.
Neuroimage. Clinical|September 22, 2022
Selective atrophy of the cervical enlargement in whole spinal cord MRI of amyotrophic lateral sclerosisRobert L Barry, Angel Torrado-Carvajal, John E Kirsch, et al.
Annals of Neurology|March 9, 2018
Myelin abnormality in Charcot-Marie-Tooth type 4J recapitulates features of acquired demyelinationBo Hu, Megan McCollum, Vignesh Ravi, et al.
Brain : a Journal of Neurology|January 30, 2024
Characterization of cortico-meningeal translocator protein expression in multiple sclerosisElena Herranz, Constantina A Treaba, Valeria T Barletta, et al.
Muscle & Nerve|September 19, 2024
Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosisJames D Berry, Sabrina Paganoni, Matthew B Harms, et al.
Muscle & Nerve|March 21, 2025
An Expanded Access Protocol of RNS60 in Amyotrophic Lateral SclerosisGrace Addy, Erica Scirocco, Dario Gelevski, et al.
Muscle & Nerve|June 29, 2026
At-Home Versus in-Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform TrialEric A Macklin, James D Berry, Brittney A Harkey, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 15, 2019
Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosisSuma Babu, Eric A Macklin, Katherine E Jackson, et al.
Neuroimage. Clinical|May 21, 2021
Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trialSuma Babu, Baileigh G Hightower, James Chan, et al.
Pageof 16